| 英文品名 |
telavancin |
| 名稱來源 |
p-INNList-91,2004;r-INNList-53,2005; |
| 化學(xué)表述 |
(3S,6R,7R,22R,23S,26S,36R,38aR)-3-(2-amino-2-oxoethyl)-10,19-dichloro-44-[(3-{[2-(decanylamino)ethyl]amino}-2,3,6-trideoxy-3-C-methyl-α-L-lyxo-hexopyranosyl-(1→2)-β-D-glucopyranosyl)oxy]-7,22,28,30,32-pentahydroxy-6-[(2R)-4-methyl-2-(methylamino)pentanamido]-2,5,24,38,39-pentaoxo-29-{[(phosphonomethyl)amino]methyl}-2,3,4,5,6,7,23,24,25,26,36,37,38,38a-tetradecahydro-1H,22H-23,36-(epiminomethano)-8,11:18,21-dietheno-13,16:31,35-bis(metheno)[1,6,9]oxadiazacyclohexadecino[4,5-m][10,2,16]benzoxadiazacyclotetracosine-26-carboxylic acid |
| CA登記號 |
372151-71-8 |
| 分 子 式 |
C80H106Cl2N11O27P |
| 結(jié) 構(gòu) 式 |
 |
| 品種類別 |
抗生素>糖肽類 |
|
